BlackRock Institutional Trust’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-106,739
Closed -$413K 3979
2015
Q1
$413K Sell
106,739
-5,383
-5% -$19.9K ﹤0.01% 3538
2014
Q4
$405K Sell
112,122
-6,436
-5% -$17K ﹤0.01% 3536
2014
Q3
$315K Buy
118,558
+18,807
+19% +$126K ﹤0.01% 3560
2014
Q2
$1.16M Buy
99,751
+39,000
+64% +$442K ﹤0.01% 3401
2014
Q1
$849K Buy
60,751
+18,147
+43% +$285K ﹤0.01% 3462
2013
Q4
$757K Buy
42,604
+19,147
+82% +$311K ﹤0.01% 3470
2013
Q3
$395K Buy
+23,457
New +$329K ﹤0.01% 3560

Other funds holding MBII

BlackRock Institutional Trust's MBII Position: Q2 2015 in Review

BlackRock Institutional Trust sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2015, closing a stake of 106,739 shares — an estimated $413K sold.

BlackRock Institutional Trust first reported a position in MBII in Q3 2013 and held it in 7 quarters. The position peaked at $1.16M in Q2 2014. 38 funds tracked by Wall St. Rank hold MBII as of Q2 2015.

  • BlackRock Institutional Trust reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2015 after selling out during the quarter.
  • BlackRock Institutional Trust sold 106,739 Marrone Bio Innovations, Inc. shares in Q2 2015, an estimated $413K.
  • BlackRock Institutional Trust first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 7 quarters.
  • BlackRock Institutional Trust's Marrone Bio Innovations, Inc. position peaked at $1.16M in Q2 2014.
  • 38 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2015.

Based on BlackRock Institutional Trust's 13F filing for Q2 2015, filed 7 Aug 2015.